RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial–mesenchymal transition via MAPK/SOX2 pathway in bladder cancer
2017 · Cell Death and Disease · 57 citations
https://doi.org/10.1038/cddis.2017.9
K
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
198
Papers
3.3K
Citations
36
h-index
78
i10-index
Kaijie Wu is an academic researcher from First Affiliated Hospital of Xi'an Jiaotong University. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Bladder and Urothelial Cancer Treatments & Cancer, Lipids, and Metabolism. The author has an h-index of 36, co-authored 169 publications.
ORCID: 0000-0002-7438-3804Papers by this author
worksMUC15 inhibits cancer metastasis via PI3K/AKT signaling in renal cell carcinoma
2020 · Cell Death and Disease · 46 citations
https://doi.org/10.1038/s41419-020-2518-9
The roles and mechanism of IFIT5 in bladder cancer epithelial–mesenchymal transition and progression
2019 · Cell Death and Disease · 41 citations
https://doi.org/10.1038/s41419-019-1669-z
Reciprocal Regulation of Hypoxia-Inducible Factor 2α and GLI1 Expression Associated With the Radioresistance of Renal Cell Carcinoma
2014 · International Journal of Radiation Oncology*Biology*Physics · 36 citations
https://doi.org/10.1016/j.ijrobp.2014.06.065
Activation of type 4 metabotropic glutamate receptor promotes cell apoptosis and inhibits proliferation in bladder cancer
2018 · Journal of Cellular Physiology · 27 citations
https://doi.org/10.1002/jcp.27089
RASAL2 regulates the cell cycle and cyclin D1 expression through PI3K/AKT signalling in prostate tumorigenesis
2022 · Cell Death Discovery · 15 citations
https://doi.org/10.1038/s41420-022-01069-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat